IDT Australia
1975
FOUNDED
PUBLIC
STATUS
101-200
EMPLOYEES
IDT
STOCK SYMBOL
2
INVESTMENTS
$0.11
SHARE PRICE
(As of Friday Closing)
Description
IDT Australia Ltd produces, develops and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company specializes in the post-discovery pharmaceutical life cycle. The company offers research and development, validation, and testing services for API, including cytotoxics, anti-cancer drugs, antibiotics, beta lactams, and controlled drugs, as well as generic medicines into finished dosage forms. Its services also include laboratory, functional support, project management, chemical, analytical chemistry, pharmacy, clinical packaging.
Website
Formerly Known As
Institute of Drug Technology Australia
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
ASX
Primary Office
- 45 Wadhurst Drive
- Boronia, Victoria 3155
- Australia
+61 (03) 0000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore IDT Australia’s full profile, request a free trial.
IDT Australia Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $0.05 - $0.17 | $25.4M | $0.11 | 470K | 237M |
IDT Australia Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2018
|
FY 2018
30-Jun-2018
|
FY 2017
30-Jun-2017
|
FY 2016
30-Jun-2016
|
|---|---|---|---|---|
| Enterprise Value | 18,162 | 7,728 | 14,066 | 38,777 |
| Revenue | 10,759 | 9,986 | 7,005 | 12,293 |
| EBITDA | (810) | (12,463) | (9,611) | (2,518) |
| Net Income | (1,619) | (13,152) | (583) | (2,918) |
| Total Assets | 24,495 | 28,584 | 44,659 | 39,513 |
| Total Debt | 337 | 398 | 510 | 1,936 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
IDT Australia Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 (0000000 00 | 01-Oct-2014 | 000000000 00000 00 | 0000 | Pharmaceuticals | |
| CMAX | 27-May-2002 | Merger/Acquisition | Laboratory Services (Healthcare) | 000000 00000000 |
IDT Australia Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Paul MacLeman | Managing Director | ||
| Graeme Blackman | Chairman | ||
| Jane Kelly | Vice President, Clinical Services |
IDT Australia Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 000000 00000000 | IDT Australia | Chairman | 000 0000 |